SMD Rise PCLBKK:SMD100-R 59 EV-to-EBITDA is 5.46 as of Jul. 08, 2026, which is 28% below its 10-year median of 7.60. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿24.10. The stock has 6 warning signs investors should review. Among 97 Medical Distribution companies, SMD Rise PCL ranks better than 71.13% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, SMD Rise PCL's enterprise value is ฿457.0 Mil.
SMD Rise PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿83.7 Mil. Therefore, SMD Rise PCL's EV-to-EBITDA for today is 5.46.
The historical rank and industry rank for SMD Rise PCL's EV-to-EBITDA or its related term are showing as below:
BKK:SMD100-R'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.03 Med: 7.6 Max: 16.06
Current: 5.46
During the past 8 years, the highest EV-to-EBITDA of SMD Rise PCL was 16.06. The lowest was 3.03. And the median was 7.60.
BKK:SMD100-R's EV-to-EBITDA is ranked better than 71.13% of 97
companies
in the Medical Distribution industry
Industry Median: 8.95
vs BKK:SMD100-R: 5.46
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SMD Rise PCL's PE Ratio (TTM) for today is calculated as:
SMD Rise PCL's share price for today is ฿5.85.
SMD Rise PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for SMD Rise PCL's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, CAH, COR: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, SMD Rise PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's EV-to-EBITDA falls into.
SMD Rise PCL's current Enterprise Value is ฿457.0 Mil.
SMD Rise PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿83.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL (BKK:SMD100-R) has a EV-to-EBITDA of 5.46 as of Jul. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SMD Rise PCL. This is 28% below median its historical median of 7.60. Over the past decade, SMD Rise PCL's EV-to-EBITDA has ranged from 3.03 to 16.06. According to the industry distribution chart, SMD Rise PCL ranks #28 out of 97 companies in the Medical Distribution industry, placing it in the top 28.9%.
Is SMD Rise PCL's EV-to-EBITDA too high?
SMD Rise PCL's current EV-to-EBITDA of 5.46 is 28% below median its 10-year median of 7.60. Over the past 10 years, this metric has ranged from a low of 3.03 to a high of 16.06. The Medical Distribution industry median EV-to-EBITDA is 8.95. SMD Rise PCL's value of 5.46 is 39% below this industry median. Based on the distribution chart, SMD Rise PCL ranks #28 out of 97 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's EV-to-EBITDA compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #28 out of 97 companies for EV-to-EBITDA. This puts SMD Rise PCL in the upper half of its industry. The industry median EV-to-EBITDA is 8.95. SMD Rise PCL's value of 5.46 is 39% below this benchmark. Historically, SMD Rise PCL's own EV-to-EBITDA has ranged from 3.03 to 16.06 over the past decade. While the company's 10-year median is 7.60 vs. the industry median of 8.95, SMD Rise PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.95, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current EV-to-EBITDA of 5.46 is 39% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on SMD Rise PCL. For the Medical Distribution industry, the median EV-to-EBITDA is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current EV-to-EBITDA is 5.46, which is 28% below median its own 10-year median of 7.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current EV-to-EBITDA of 5.46. The stock's GF Value™ is ฿24.10, compared to a current price of ฿5.85 — trading 75.7% below its estimated fair value. The current EV-to-EBITDA is 5.46, which is 28% below median its 10-year median of 7.60 and 39% below the Medical Distribution industry median of 8.95. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current EV-to-EBITDA is 5.46 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 75.7% below its estimated GF Value™ of ฿24.10.
Key valuation signals for BKK:SMD100-R:
EV-to-EBITDA: 5.46 (28% below median its 10-year median of 7.60)
GF Value™: ฿24.10 vs. price of ฿5.85 (75.7% below fair value)
Industry Position: 39% below the Medical Distribution median (#28 of 97)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
